⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 12, 2026Liver International

Confounding Metabolic Therapies and Weight Dynamics in Evaluating Essential Phospholipids for MASLD

Yuhan Lin Yuanyue Song

View at Publisher

Ask AI

Bookmark

Share

Key Points

This research aims to explore the impact of essential phospholipids on weight dynamics in metabolic therapies for MASLD.
Data sharing is not applicable, indicating no datasets were generated or analyzed in this context.
The study does not provide specific results due to the lack of data generation or analysis.

Implication

Investigates metabolic therapies on weight dynamics in MASLD, suggesting new intervention strategies.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lin et al. (2026) studied this question.

synapsesocial.com/papers/6a06b81ce7dec685947aaa2e https://doi.org/10.1111/liv.70689

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Comparison of Data-Driven Phenotyping Systems for metabolic Dysfunction-Associated Steatotic Liver Disease: Implications for Treatment Responsecohort · 2026
2Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapy2024 · 16 citations
3Obesity and Metabolic Dysfunction‐Associated Steatotic Liver Disease ( <scp>MASLD</scp> ): A Literature Review on Pathophysiology and TreatmentNarrative Review · 2026 · 26 citations
4Lipid Metabolic Reprogramming and Bioactive Lipid Signaling in MASLD: Molecular Mechanisms, Pathogenesis and Therapeutic OpportunitiesReview · 2026
5Dysfunctional VLDL metabolism in MASLDreview · 2024 · 26 citations

Response to Comments on ‘Effect of Essential Phospholipids in Metabolic Dysfunction‐Associated Steatotic Liver Disease’2026
Metabolic Comorbidities Modulate the Impact of Weight Loss on Liver Fibrosis in MASLD: A Real World Prospective Cohor Study2025
Clinically distinct metabotypes of pediatric MASLD identified through unsupervised clustering of NASH CRN data2026
Reductions in Advanced Chronic Liver Disease Among People Who Inject Drugs: The ETHOS Engage StudyLiver International · 2026
PIH1D2 Loss‐of‐Function Directs Ciliary and Cell Cycle Defects Resulting in Left Isomerism With or Without Biliary AtresiaLiver International · 2026

More from Liver International

More from Southwest Medical University